-
Mashup Score: 0Asian American Patients With Allergic Diseases: Considerations for Research and Clinical Care - 2 year(s) ago
The Asian American population includes Asian people who have immigrated to the United States as well as those born in the United States with Asian ancestry. Comprising nearly 24 million people, the Asian American population is one of the fastest growing racial and ethnic populations in the United States1 and is highly heterogeneous: Asian American individuals self-identify from more than 20…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 7
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 2
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
Categories: Endocrinology, Latest HeadlinesTweet
In Current Issue (Free)! #Asian #American #Patients With #Allergic #Diseases: Considerations for #Research and #Clinical #Care https://t.co/6BeyUJkNSV https://t.co/xL3CrkSH8j